Meet-the-Professor Session:
83. Management of Severe Viral Respiratory Infections
Friday, October 4, 2013: 7:00 AM-8:15 AM
Room: The Moscone Center: 130-131 (Hall E)

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • identify current trends in epidemiology of zoonotic respiratory viral threats
  • outline current treatment guidelines for adults and children hospitalised with influenza
  • describe treatment options for severe illness due to other respiratory viruses, including those in immmunocompromised hosts
  • identify antiviral resistance patterns and and investigational treatment modalities in influenza

Target Audience: vaccinologists, public health practitioners, pharmacists, nurses, microbiologists, members-in-training, investigators, infectious diseases physicians, infectious diseases pediatricians, infection preventionists, hospital epidemiologists, hospital administrators, health care workers, fellows, epidemiologists, clinicians, academicians

Tracks: Pediatric ID, Investigative ID, Global ID, Epidemiology and Infection Control, Adult ID

Meet-the-Professor:  Frederick Hayden, MD, FIDSA, University of Virginia Health Sciences Center


CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 CreditTM

ACPE Credits: ACPE 1.25 knowledge-based contact hours (0.125 CEU) of pharmacy CE

ACPE Number: 0221-9999-13-126-L01-P


F. Hayden, Sanofi-Pasteur: Member DSMB for influenza vaccine trial, Honoraria to University of Virginia
Law firms (multiple): Consultant and Expert witness, Consulting fee and Consulting fees to University of Virginia
Companies (multiple): Non-compensated consultant , Travel support to attend on-site meetings

Findings in the abstracts are embargoed until 12:01 a.m. PST, Oct. 2nd with the exception of research findings presented at the IDWeek press conferences.